Anders Kvanta: Clinical Trials

2 trials sponsored by Anders Kvanta, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Anders Kvanta: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bevacizumab for Central Retinal Vein Occlusion Study
bevacizumab, Sham bevacizumab injection - Central Retinal Vein Occlusion
Phase 3CompletedAnders Kvanta602009-05-012011-11-22
The Ranibizumab Plus Transpupillary Thermotherapy for Neovascular Age-Related Macular Degeneration (AMD) Study
ranibizumab, TTT, Sham TTT - Neovascular Age-related Macular Degeneration
Phase 3CompletedAnders Kvanta1002008-02-012011-11-22

Conditions studied

Macular Degeneration (1)  ·  Macular Edema (1)  ·  Retinal Vein Occlusion (1)

Interventions

Bevacizumab (1)  ·  Ranibizumab (1)

Countries

Sweden (2)

Results publications

PMID 22241923